Quarterly pharmacy formulary change

Size: px
Start display at page:

Download "Quarterly pharmacy formulary change"

Transcription

1 Medi-Cal Managed Care L. A. Care Major Risk Medical Insurance Program Provider Bulletin The formulary changes listed in the table below were reviewed and approved at our first-quarter 2018 Pharmacy and Therapeutics Committee meeting. Effective August 1, 2018, these changes will apply to Anthem Blue Cross members. June 2018 Effective for members new to therapy on August 1, 2018, and existing members on October 1, 2018 Therapeutic class Drug name Revised status APIDRA 100 UNITS/ML VIAL APIDRA SOLOSTAR 100 UNITS/ML EFFECTIVE FOR NEW STARTS ON 8/1/18; EFFECTIVE FOR ON 10/1/18 Effective for all members on August 1, 2018 Therapeutic class Drug Revised status (EDIT ONLY) ADMELOG 100 UNIT/ML VIAL ADMELOG SOLOSTAR 100 UNIT/ML HUMULIN R 500 UNITS/ML VIAL HUMULIN R 500 UNITS/ML KWIKPEN 30MLS PER 30 DAYS ADDING PA TO PRODUCT Potential alternatives ADMELOG 100 UNIT/ML VIAL ADMELOG SOLOSTAR 100 UNIT/ML Potential alternatives ANTIPERSPIRANTS HYPERCARE 15% SOLUTION DPP4s GLP1s GLP1s ICS/LABA JENTADUETO 2.5 MG-1000 MG TAB JENTADUETO 2.5 MG-500 MG TAB JENTADUETO 2.5 MG-850 MG TAB JENTADUETO XR 2.5 MG-1,000 MG JENTADUETO XR 5 MG-1,000 MG TB TRADJENTA 5 MG TABLET TANZEUM 30 MG PEN INJECT TANZEUM 50 MG PEN INJECT OZEMPIC MG DOSE PEN OZEMPIC 1 MG DOSE PEN (AUTHORIZED GENERIC OF AIRDUO RESPICLICK) FLUTICASONE-SALMETEROL FLUTICASONE-SALMETEROL FLUTICASONE-SALMETEROL WITH STEP EFFECTIVE 4/1/18 Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. ANTHEM is a registered trademark of Anthem Insurance Companies, Inc. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. ACAPEC June 2018 JANUVIA JANUMET XR ST APPLIES OZEMPIC VICTOZA ST APPLIES

2 ICS/LABA IRON SUPPLEMENTS MISCELLANEOUS ANTINEOPLASTIC DRUGS MISCELLANEOUS OPHTHALMOLOGICS DULERA 100 MCG/5 MCG INHALER DULERA 200 MCG/5 MCG INHALER POLY-VI-SOL WITH IRON DROPS POLY-VI-SOL DROPS MITOXANTRONE 20 MG/10 ML VIAL MITOXANTRONE 25 MG/12.5 ML VIAL MITOXANTRONE 30 MG/15 ML VIAL IMMUNOMODULATORS PROLEUKIN 22 MILLION UNIT VIAL Anthem Blue Cross Page 2 of 5 COVERED * AUTHORIZED GENERIC FOR AIDUO RESPICLK FLUTICASONE- SALMETEROL BREO ELLITA VISUDYNE 15 MG VIAL COVERED ADD PA LAMA/LABA STIOLTO RESPIMAT INHAL SPRAY PHOSPHATE BINDERS PHOSPHATE BINDERS LANTHANUM CARB 500 MG TAB CHEW LANTHANUM CARB 750 MG TAB CHEW LANTHANUM CARB 1,000 MG TB CHW SEVELAMER 0.8 GM POWDER PACKET SEVELAMER 2.4 GM POWDER PACKET SEVELAMER CARBONATE 800 MG TAB VELPHORO 500 MG CHEWABLE TAB WITH PA ELIPHOS 667 MG TABLET CALCIUM ACETATE 667 MG LANTHANUM CHEW TAB SEVELAMER TAB/PACKET PRENATAL VITAMINS GENERIC OTC PRODUCTS ONLY PRENATAL VITAMINS BRAND OTC ALL RX PRODUCTS EDITS No changes in preferred/nonpreferred status revision or addition to UM edit only. ANTICONVULSANTS ZONEGRAN 100 MG CAPSULE GENERIC OTC PRENATALS

3 ANTIBIOTICS COUGH AND COLD COUGH AND COLD ANTIVIRALS ANTIVIRALS BAXDELA 450 MG TABLET COUGH AND COLD PRODUCTS CONTAINING HYDROCODONE COUGH AND COLD PRODUCTS CONTAINING CODEINE PREVYMIS 240 MG/12 ML VIAL PREVYMIS 480 MG/24 ML VIAL PREVYMIS 240 MG TABLET PREVYMIS 480 MG TABLET Anthem Blue Cross Page 3 of 5 28 TABLETS PER FILL; 1 FILL PER 30 DAYS ADD AL MEMBERS EQUAL TO OR LESS THAN 18 REQUIRE PA ADD AL MEMBERS EQUAL TO OR LESS THAN 18 REQUIRE PA 1 VIAL PER DAY 100 DAYS OF TREATMENT 100 DAYS OF TREATMENT ASTHMA XOPENEX 30 VIALS 90 VIALS PER 30 DAYS BILE ACIDS CONSTIPATION AGENTS GLP-1 RECEPTOR AGONIST GLP-1 RECEPTOR AGONIST HEPATITIS C TREATMENT AGENTS ICS ICS LIPID/CHOLESTEROL LOWERING AGENTS CHENODAL 250 MG TABLET ALUNBRIG 180 MG TABLET ALUNBRIG 90 MG-180 MG TAB PACK ALUNBRIG 90 MG TABLET SYMPROIC 0.2 MG TABLET BROVANA 15 MCG/2 ML SOLUTION PERFOROMIST 20 MCG/2 ML SOLN LONHALA MAGNAIR 25 MCG STARTER LONHALA MAGNAIR 25 MCG REFILL OZEMPIC MG DOSE PEN OZEMPIC 1 MG DOSE PEN PEGINTRON 50 MCG KIT PEGASYS 180 MCG/0.5 ML SYRINGE PEGASYS 180 MCG/ML VIAL PEGASYS PROCLICK 180 MCG/0.5 PEGASYS PROCLICK 135 MCG/0.5 QVAR REDIHALER 40 MCG QVAR REDIHALER 80 MCG FLOLIPID 7 TABLETS PER DAY 1 PACK IN 30 DAYS REVISED QL 2 TABLETS DAILY 2 VIALS (4ML) PER DAY 2 VIALS (4ML) PER DAY 1 KIT PER 30 DAYS 1 PER 30 DAYS 1 PEN PER 28 DAYS 2 PENS PER 28 DAYS REMOVE PA 1 INHALER PER 30 DAYS 2 INHALERS PER 30 DAYS 5MLS PER DAY

4 Anthem Blue Cross Page 4 of 5 NUEDEXTA MG CAPSULE INGREZZA 40 MG CAPSULE INGREZZA 80 MG CAPSULE NEUROPATHIC PAIN LYRICA 82.5 NEUROPATHIC PAIN LYRICA 165 NEUROPATHIC PAIN LYRICA 330 PANCREATIC ENZYMES PANCREATIC ENZYMES POTASSIUM SPARING DIURETICS PROGESTINS PSYCHOTHERAPEUTIC AGENTS PULMONARY ARTERIAL HYPERTENSION /DPP-4 INHIBITOR SUBSTANCE USE DISORDERS PERTZYE DR 24,000 UNIT CAPSULE VIOKASE CAROSPIR 25 MG/5 ML SUSPENSION CRINONE 4% GEL CRINONE 8% GEL ADZENYS ER 1.25 MG/ML SUSP TRACLEER 32 MG TABLET FOR SUSP XIGDUO XR 2.5 MG-1,000 MG TAB STEGLATRO 5 MG TABLET STEGLATRO 15 MG TABLET SEGLUROMET 7.5-1,000 MG TABLET SEGLUROMET MG TABLET SEGLUROMET MG TABLET SEGLUROMET 2.5-1,000 MG TABLET STEGLUJAN MG TABLET STEGLUJAN MG TABLET SUBLOCADE 300 MG/1.5 ML SYRING SUBLOCADE 100 MG/0.5 ML SYRING LOPROX 0.77% CREAM LOTRIMIN ULTRA 1% CREAM NYSTATIN 100,000 UNIT/GM CREAM NYSTATIN 100,000 UNITS/GM OINT KETOCONAZOLE 2% CREAM OXISTAT 1% CREAM 2 CAPSULES PER DAY REVISED QL 25 CAPSULES PER DAY 25 TABLETS PER DAY ADD PA AND QL 20ML PER DAY 1 APPLICATORFUL PER DAY 15ML PER DAY 32 MG TABS FOR SUSP 4 TABLETS PER DAY 2 TABLETS PER DAY 2 TABLETS PER DAY 1 SYRINGE EVERY 28 DAYS 90 GMS PER 30 DAYS 30 GMS PER 30 DAYS 120 GMS PER 30 DAYS 60 GMS PER 30 DAYS

5 Anthem Blue Cross Page 5 of 5 What action do I need to take? Please review these changes and work with your members to transition them to formulary alternatives. If you determine preferred formulary alternatives are not clinically appropriate for specific patients, you will need to obtain prior authorization to continue coverage beyond the applicable effective date. What if I need assistance? We recognize the unique aspects of members cases. If for medical reasons your member cannot be converted to a formulary alternative, please call our Pharmacy department at and follow the voice prompts for pharmacy prior authorization. You can find the Preferred Drug List on our provider website at If you need assistance with any other item, contact the Customer Care Center at (outside L.A. County) or (inside L.A. County).

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Quarterly pharmacy formulary change notice Provider update Summary: Effective August 1, 2018, the preferred formulary changes detailed in the table below will apply to District of Columbia Healthy Families

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Provider update Quarterly pharmacy formulary change notice Summary: The formulary changes listed in the table below were reviewed and approved at our first-quarter 2018, Pharmacy and Therapeutics Committee

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Provider Bulletin October 2018 Quarterly pharmacy formulary change notice The formulary changes listed in the table below apply to all Anthem HealthKeepers Plus patients. The changes listed in the table

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Quarterly pharmacy formulary change notice The formulary changes listed in the table below were reviewed and approved at our second quarter 2018 Pharmacy and Therapeutics Committee meeting. Effective October

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice MEDICAID PROVIDER BULLETIN October 2018 The formulary changes listed in the table below were reviewed and approved at the second-quarter 2018 Pharmacy and Therapeutics Committee meeting. Effective October

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Provider Bulletin April 2018 This table is used by HealthKeepers, Inc. to indicate formulary changes applicable to all Anthem HealthKeepers Plus members. These changes were reviewed and approved at the

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Provider Bulletin June 2017 The formulary changes listed in the table below apply to all Anthem HealthKeepers Plus patients. These changes were reviewed and approved at the first quarter Pharmacy and Therapeutics

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice MEDICAID PROVIDER BULLETIN March 2019 Quarterly pharmacy formulary change notice The formulary changes listed in the table below were reviewed and approved at the fourth quarter pharmacy and therapeutics

More information

HEALTH SHARE/PROVIDENCE (OHP)

HEALTH SHARE/PROVIDENCE (OHP) HEALTH SHARE/PROVIDENCE (OHP) STEP THERAPY This is a complete list of drugs that have written coverage determination policies. Drugs on this list do not indicate that this particular drug will be covered

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Quarterly pharmacy formulary change notice Provider update Summary: The formulary changes listed in the table below were reviewed and approved at our second quarter 2018, Pharmacy and Therapeutics Committee

More information

AETNA BETTER HEALTH January 2017 Formulary Change(s)

AETNA BETTER HEALTH January 2017 Formulary Change(s) AETNA BETTER HEALTH January 2017 Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on March 1, 2017 Drug Name, Strength, Dosage Form ALFUZOSIN HCL ER 10

More information

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0. ANTI DIABETICS BYDUREON 2 MG SUBCUTANEOUS JANUVIA 25 MG TABLET EXTENDED RELEASE SUSPENSION JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET

More information

Quarterly Pharmacy Formulary Change Notice

Quarterly Pharmacy Formulary Change Notice MEDICAID PROVIDER BULLETIN February 26, 2015 Quarterly Pharmacy Formulary Change Notice Summary of Change: The formulary changes listed in the table below were reviewed and approved at our September 24,

More information

AETNA BETTER HEALTH January 2017 Formulary Change(s)

AETNA BETTER HEALTH January 2017 Formulary Change(s) AETNA BETTER HEALTH January 2017 Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on February 1, 2017 Drug Name, Strength, Dosage Form IVERMECTIN 3 MG TABLET

More information

Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria

Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria Medications that require Step Therapy (ST) require trial and failure of preferred formulary agents prior to their authorization. If the prerequisite medications have been filled within the specified time

More information

2018 Step Therapy Criteria (List of Step Therapy Criteria)

2018 Step Therapy Criteria (List of Step Therapy Criteria) Step Therapy Criteria Last Updated: March 20, 2018 Effective Date: April 1, 2018 2018 Step Therapy Criteria (List of Step Therapy Criteria) PLEASE READ CAREFULLY: IEHP DUALCHOICE CAL MEDICONNECT PLAN (MEDICARE-MEDICAID

More information

Aetna Better Health of Illinois Medicaid Formulary Updates

Aetna Better Health of Illinois Medicaid Formulary Updates October 2017 o DOXYLAMINE SUCCINATE 25mg-QL o DULOXETINE CAP 40MG DR-QL o GUANFACIN ER TABS (all strengths)-ql o TOBRAMYCIN NEBU SOLUTION- PA August 2017 Aetna Better Health of Illinois Medicaid 2017 Formulary

More information

Health Partners Medicare Prime 2019 Formulary Changes

Health Partners Medicare Prime 2019 Formulary Changes Health Partners Medicare Prime 2019 Formulary Changes Changes occur, for example, because new drugs come on the market, a drug is moved to a different cost-sharing level (tier), or a generic version becomes

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice The formulary changes listed in the table below apply to all Anthem HealthKeepers Plus and Anthem HealthKeepers Plus, Commonwealth Coordinated Care Plus (Anthem CCC Plus) members. These formulary changes,

More information

2018 Step Therapy Criteria (List of Step Therapy Criteria)

2018 Step Therapy Criteria (List of Step Therapy Criteria) Criteria Last Updated: October 05, 2017 Effective Date: January 1, 2018 2018 Step Therapy Criteria (List of Step Therapy Criteria) PLEASE READ CAREFULLY: IEHP DUALCHOICE CAL MEDICONNECT PLAN (MEDICARE-

More information

HOW TO USE THE FORMULARY

HOW TO USE THE FORMULARY INTRODUCTION The information contained in the Willamette Valley Community Health (WVCH) WRAP/D-Excluded Formulary and its appendices is provided solely for the convenience of medical providers. WVCH does

More information

Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates

Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates July 2018 TRADE NAME (generic name) or generic name ADVAIR DISKUS (fluticasone-salmeterol aer powder ba 100-50 mcg/dose) Brand Addition ADVAIR

More information

March 2018 P & T Updates

March 2018 P & T Updates March 2018 P & T Updates Commercial Triple Tier 4th Tier Applicable Traditional Prior Auth AURYXIA 3 2 12 tablets per BAXDELA TABLETS 3 2 2 tablets per Depending on your specific benefits and in which

More information

Step Therapy Requirements

Step Therapy Requirements An Independent Licensee of the Blue Cross and Blue Shield Association Step Therapy Requirements Effective: 05/01/2018 Updated 4/2018 H0302_2_2014 CMS Accepted 05/05/2014 1 BETA-BLOCKERS BYSTOLIC 10 MG

More information

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM Value Based Tier Drugs are selected for the management of Asthma, Diabetes, Hypertension and Hyperlipidemia. These drugs are covered at no charge or at a reduced cost share. Medications are under continual

More information

Step Therapy Criteria

Step Therapy Criteria Tier 5 Formulary Step Therapy 2016 Updated: 05/24/2016 Effective: 06/01/2016 What is Step Therapy? Some prescription drugs require step therapy (ST). In some cases, the plan requires you to first try certain

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Serving Hoosier Healthwise, Healthy Indiana Plan and Hoosier Care Connect May 2018 Quarterly pharmacy formulary change notice Effective May 1, 2018, the preferred formulary changes detailed in the table

More information

QUANTITY LIMIT CRITERIA. BROVANA (arformoterol tartrate) SEREVENT DISKUS (salmeterol) STRIVERDI RESPIMAT (olodaterol)

QUANTITY LIMIT CRITERIA. BROVANA (arformoterol tartrate) SEREVENT DISKUS (salmeterol) STRIVERDI RESPIMAT (olodaterol) Carelirst. +.V Family of health care plans DRUG CLASS COMBINATIONS QUANTITY LIMIT CRITERIA LONG ACTING BETA2-ADRENERGIC AGONIST, ORAL INHALATION BRAND NAME (generic) LONG-ACTING BETA2-ADRENERGIC AGONISTS:

More information

San Francisco Health Plan (SFHP)

San Francisco Health Plan (SFHP) 3T... 3T... harmacy and Therapeutics Committee Quarterly Formulary and rior Authorization Criteria Update San Francisco Health lan (SFH) Quarterly Formulary and rior Authorization Criteria Update The following

More information

Health Partners Medicare Special 2018 Formulary Changes

Health Partners Medicare Special 2018 Formulary Changes Health Partners Medicare Special 2018 Changes Changes occur, for example, because new drugs come on the market, a drug is moved to a different cost-sharing level (tier), or a generic version becomes available.

More information

Emblem Medicaid 3Q18 Formulary Updates

Emblem Medicaid 3Q18 Formulary Updates ALKERAN 2 MG TABLET Removed from Formulary 7/9/2018 AMITIZA 24 MCG CAPSULES Removed from Formulary 7/9/2018 AMITIZA 8 MCG CAPSULE Removed from Formulary 7/9/2018 avo cream topical emulsion Removed from

More information

Neighborhood Medicaid Formulary Changes: June 2017

Neighborhood Medicaid Formulary Changes: June 2017 Neighborhood Medicaid Formulary Changes: June 2017 The following changes to the Neighborhood Medicaid Formulary were recently approved by the Pharmacy and Therapeutics (P&T) Committee. All changes were

More information

2018 Step Therapy (ST) Criteria

2018 Step Therapy (ST) Criteria 2018 Step Therapy (ST) Some drugs require step therapy pre-approval. This means that your doctor must have you first try a different drug to treat your medical condition before we will cover a drug that

More information

2017 Step Therapy (ST) Criteria

2017 Step Therapy (ST) Criteria 2017 Step Therapy (ST) Some drugs require step therapy pre-approval. This means that your doctor must have you first try a different drug to treat your medical condition before we will cover a drug that

More information

San Francisco Health Plan (SFHP)

San Francisco Health Plan (SFHP) San Francisco Health Plan (SFHP) The following changes to SFHP formulary and prior authorization criteria were reviewed and approved by the SFHP Pharmacy and Therapeutics (P&T) Committee on 07/18/2018.

More information

Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir

Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir Acyclovir Ointment Mercy Care Plan acyclovir ointment 5 % external Requires use of oral Acyclovir 1 Adcirca ADCIRCA TABLET 20 MG ORAL Requires use of Sildenafil 2 Albenza ALBENZA TABLET 200 MG ORAL Requires

More information

2018 CareOregon Advantage Part D Formulary Changes

2018 CareOregon Advantage Part D Formulary Changes 2018 CareOregon Advantage Part D Formulary Changes Abbreviations: AGE = Age Restriction; PA = Prior Authorization Required; QL = Quantity Limit; ST = Step Therapy Required; LD = Limited Distribution; BvD

More information

San Francisco Health Plan (SFHP)

San Francisco Health Plan (SFHP) San Francisco Health Plan (SFHP) The following changes to SFHP formulary and prior authorization criteria were reviewed and approved by the SFHP Pharmacy and Therapeutics (P&T) Committee on 04/18/2018.

More information

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements 2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements AlohaCare requires you to first try one drug to treat your medical condition before we will cover another drug for

More information

Drugs That Require Step Therapy (ST) Step Therapy Medications

Drugs That Require Step Therapy (ST) Step Therapy Medications Drugs That Require Step Therapy (ST) In some cases, BlueShield of Northeastern New York requires you to first try certain drugs to treat your medical condition before we will cover another drug for that

More information

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements 2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements AlohaCare requires you to first try one drug to treat your medical condition before we will cover another drug for

More information

Provider update: Quarterly pharmacy formulary change notice

Provider update: Quarterly pharmacy formulary change notice Serving Hoosier Healthwise and Healthy Indiana Plan November 5, 2015 Provider update: Quarterly pharmacy formulary change notice Effective December 1, 2015, the preferred formulary changes detailed in

More information

Quarterly pharmacy formulary change

Quarterly pharmacy formulary change Medi-Cal Managed Care Access for Infants and Mothers/Medi-Cal Access Program L. A. Care Major Risk Medical Insurance Program November 5, 2015 Quarterly pharmacy formulary change The formulary changes listed

More information

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements 2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements AlohaCare requires you to first try one drug to treat your medical condition before we will cover another drug for

More information

Drugs That Require Step Therapy (ST) Step Therapy Medications

Drugs That Require Step Therapy (ST) Step Therapy Medications Drugs That Require Step Therapy (ST) In some cases, BlueShield of Northeastern New York requires you to first try certain drugs to treat your medical condition before we will cover another drug for that

More information

Drugs That Require Step Therapy (ST) Step Therapy Medications

Drugs That Require Step Therapy (ST) Step Therapy Medications Drugs That Require Step Therapy (ST) In some cases, BlueCross BlueShield of WNY requires you to first try certain drugs to treat your medical condition before we will cover another drug for that condition.

More information

Formulary Medical Necessity Program

Formulary Medical Necessity Program BENEFIT APPLICATION Formulary Medical Necessity Program DRUG POLICY Benefit determinations are based on the applicable contract language in effect at the time the services were rendered. Exclusions, limitations

More information

Oregon Health Plan prescription benefit updates

Oregon Health Plan prescription benefit updates Oregon Health Plan prescription benefit updates EOCCO s prescription program is a pharmacy benefit that offers members a choice of safe and effective medication treatments. The program also helps you save

More information

ALPHA BLOCKERS. Products Affected Step 1: Details. Step 2: Rapaflo 4 mg capsule Rapaflo 8 mg capsule

ALPHA BLOCKERS. Products Affected Step 1: Details. Step 2: Rapaflo 4 mg capsule Rapaflo 8 mg capsule CHRISTUS Health Plan Generations (HMO) CHRISTUS Health Plan Generations Plus (HMO) 2018 Premier Performance Standard Step Therapy PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT SOME OF THE DRUGS

More information

Drugs That Require Step Therapy (ST) Step Therapy Medications

Drugs That Require Step Therapy (ST) Step Therapy Medications Drugs That Require Step Therapy (ST) In some cases, BlueShield of Northeastern New York requires you to first try certain drugs to treat your medical condition before we will cover another drug for that

More information

ANTICONVULSANT STEP THERAPY

ANTICONVULSANT STEP THERAPY 2019 First Choice VIP Care Plus Formulary Document: 2019 Step Therapy Formulary ID: 19391 Last Updated: 2/2019 Effective Date: 03-01-2019 ANTICONVULSANT STEP THERAPY APTIOM 200 MG APTIOM 400 MG APTIOM

More information

2018 Medicare Part D Formulary Change

2018 Medicare Part D Formulary Change 2018 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy

More information

TRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder

TRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder TRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific

More information

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select April 1, 2018 Updates Drug Name adapalene-benzoyl-peroxide Gel 0.1-2.5% (Brand = Epiduo ) prasugrel hcl (Brand = Effient ) vigabatrin pak 500 mg (Brand

More information

DPP4 INHIBITORS. Products Affected Step 2: Janumet 50 mg-1,000 mg tablet Janumet 50 mg-500 mg tablet Januvia 100 mg tablet Januvia 25 mg tablet

DPP4 INHIBITORS. Products Affected Step 2: Janumet 50 mg-1,000 mg tablet Janumet 50 mg-500 mg tablet Januvia 100 mg tablet Januvia 25 mg tablet DPP4 INHIBITORS Janumet 50 mg-1,000 mg tablet Janumet 50 mg-500 mg tablet Januvia 100 mg tablet Januvia 25 mg tablet Januvia 50 mg tablet Onglyza 2.5 mg tablet Onglyza 5 mg tablet Tradjenta 5 mg tablet

More information

Contents ALPHA BLOCKERS... 3 COLCRYS-PST... 4 DPP-4 INHIBITORS-PST... 5 HIGH RISK MEDICATIONS - SEDATIVE HYPNOTICS... 6

Contents ALPHA BLOCKERS... 3 COLCRYS-PST... 4 DPP-4 INHIBITORS-PST... 5 HIGH RISK MEDICATIONS - SEDATIVE HYPNOTICS... 6 CHRISTUS Health Plan Generations (HMO) 2017 Step Therapy Criteria H1189_PC57 Accepted 11/17/2016 1 Contents ALPHA BLOCKERS... 3 COLCRYS-PST... 4 DPP-4 INHIBITORS-PST... 5 HIGH RISK MEDICATIONS - SEDATIVE

More information

Peach State Health Plan routinely reviews the medications available on the Preferred Drug

Peach State Health Plan routinely reviews the medications available on the Preferred Drug Effective date: December 27, 2016 Peach State Health Plan Preferred Drug List (PDL) Updates Q4 2016 Peach State Health Plan routinely reviews the medications available on the Preferred Drug List (PDL).

More information

Drugs That Require Step Therapy (ST) Step Therapy Medications

Drugs That Require Step Therapy (ST) Step Therapy Medications Drugs That Require Step Therapy (ST) In some cases, HealthNow New York Inc. requires you to first try certain drugs to treat your medical condition before we will cover another drug for that condition.

More information

Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee Decisions

Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee Decisions Alameda Alliance for Health FORMULARY UPDATE Effective: October 27, 2017. Drugs notated with an * have an undetermined implementation date Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee

More information

STEP THERAPY CRITERIA

STEP THERAPY CRITERIA STEP THERAPY This is a complete list of drugs that have written coverage determination policies. Drugs on this list do not indicate that this particular drug will be covered under your medical or prescription

More information

2018 Formulary Update

2018 Formulary Update MEDICARE ADVANTAGE BlueShield of Northeastern New York 2018 Formulary Update BlueShield of Northeastern New York has updated its formulary (drug list) since its original publication in January 2018. This

More information

2018 Formulary Notice of Change Prescription Drug Plans

2018 Formulary Notice of Change Prescription Drug Plans 2018 Formulary Notice of Change Prescription Drug Plans WellCare Prescription Insurance, Inc. Plans in all states: WellCare Classic (PDP) WellCare may add or remove drugs from our formulary during the

More information

DPP4 INHIBITORS. Details. Step Therapy Criteria Health Alliance Plan 2019 Date Effective: 04/01/2019

DPP4 INHIBITORS. Details. Step Therapy Criteria Health Alliance Plan 2019 Date Effective: 04/01/2019 DPP4 INHIBITORS Janumet 50 mg-1,000 mg tablet Januvia 50 mg tablet Janumet 50 mg-500 mg tablet Onglyza 2.5 mg tablet Januvia 100 mg tablet Onglyza 5 mg tablet Januvia 25 mg tablet Tradjenta 5 mg tablet

More information

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select April 1, 2018 Updates Drug Name adapalene-benzoyl-peroxide Gel 0.1-2.5% (Brand = Epiduo ) prasugrel hcl (Brand = Effient ) vigabatrin pak 500 mg (Brand

More information

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication. ADHD STIMULANTS ATOMOXETINE HCL, DEXEDRINE 10 MG TABLET, DEXEDRINE 5 MG TABLET, DEXMETHYLPHENIDATE HCL, DEXMETHYLPHENIDATE HCL ER, DEXTROAMPHETAMINE 10 MG TAB, DEXTROAMPHETAMINE 5 MG TAB, DEXTROAMPHETAMINE

More information

ELEVATE. Formulary Updates to Elevate Plans (Bronze HDHP/Standard, Silver Select/Standard & Gold Select/Standard)

ELEVATE. Formulary Updates to Elevate Plans (Bronze HDHP/Standard, Silver Select/Standard & Gold Select/Standard) ELEVATE Formulary Updates to Elevate Plans (Bronze HDHP/Standard, Silver Select/Standard & Gold Select/Standard) P&T/Formulary Committee Actions 4Q 2017 (Effective January 1, 2018) Marketplace Standard

More information

Added, Removed or Changed. Added, Removed or Changed

Added, Removed or Changed. Added, Removed or Changed One mission: you s March 8, 2018 Blue Cross of Idaho reviews its formularies (covered drug lists) periodically to allow members access to new drugs and to provide safe, cost effective options for your

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Provider Bulletin June 24, 2016 Summary of change The Pharmacy and Therapeutics Committee reviewed and approved the formulary changes listed in the table below on March 29, 2016. What this means to you

More information

2014 Step Therapy Criteria (List of Step Therapy Criteria)

2014 Step Therapy Criteria (List of Step Therapy Criteria) Criteria Last Updated: November 1, 2014 2014 Step Therapy Criteria (List of Step Therapy Criteria) PLEASE READ CAREFULLY: IEHP MEDICARE DUALCHOICE (HMO SNP) REQUIRES YOU TO FIRST TRY CERTAIN DRUGS TO TREAT

More information

Date: October 3, 2017 To: Participating Providers From: YourCare Health Plan Provider Relations Subject: 2018 Formulary Changes

Date: October 3, 2017 To: Participating Providers From: YourCare Health Plan Provider Relations Subject: 2018 Formulary Changes Date: October 3, 2017 To: Participating Providers From: YourCare Health Plan Provider Relations Subject: 2018 Formulary Changes 2018 Formulary-UM Changes What does this mean now, and for 2018? A number

More information

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT MAY 29, 2012

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT MAY 29, 2012 IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT201218 MAY 29, 2012 Changes to the Preferred Drug List Changes to the Preferred Drug List (PDL) were made at the May 18, 2012, Drug Utilization Review (DUR)

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Quarterly pharmacy formulary change notice Summary of change: The Pharmacy and Therapeutics Committee (P&T) reviewed and approved the formulary changes listed in the table below on March 29, 2016. What

More information

Advanced Control Formulary Change Summary Report Effective

Advanced Control Formulary Change Summary Report Effective This report highlights all changes (additions, deletions, and removals) to the CVS Caremark Advanced Control Formulary ADDITIONS: Brand Agents: Austedo (deutetrabenazine) tablet Cystagon (cysteamine bitartrate)

More information

Step Therapy Requirements. Effective: 11/01/2018

Step Therapy Requirements. Effective: 11/01/2018 Effective: 11/01/2018 Updated 10/2018 ANTIDEPRESSANTS Sharp Health Plan (HMO) TRINTELLIX 10 MG TABLET TRINTELLIX 20 MG TABLET TRINTELLIX 5 MG TABLET VIIBRYD 10 MG (7)-20 MG (23) TABLETS IN A DOSE PACK

More information

Prescribing Guide Standard Control Change Summary Report Effective (Standard Drug List Reflects Removals)

Prescribing Guide Standard Control Change Summary Report Effective (Standard Drug List Reflects Removals) This report highlights all changes (additions, deletions and removals) to the CVS Caremark Prescribing Guide Standard Control. ADDITIONS: Brand Agents: Austedo (deutetrabenazine) tablet Estring (estradiol)

More information

Notice of Mid-Year Changes to 2019 Paramount Enhanced Formulary

Notice of Mid-Year Changes to 2019 Paramount Enhanced Formulary Notice of Mid-Year s to 2019 Paramount Enhanced Formulary Paramount Elite (HMO) may immediately remove a brand name drug on our List if we are replacing it with a new generic drug that will appear on the

More information

List 1 PRESCRIPTION DRUGS REQUIRING PRE-AUTHORIZATION LIBERTY HEALTH DRUG IDENTIFICATION NUMBER (DIN)

List 1 PRESCRIPTION DRUGS REQUIRING PRE-AUTHORIZATION LIBERTY HEALTH DRUG IDENTIFICATION NUMBER (DIN) PRESCRIPTION DRUGS REQUIRING PRE-AUTHORIZATION List 1 ACNE THERAPY If covered person over 30 years of age approval by Liberty Health required RETIN A CR 0.01% 00897329 RETIN A CR 0.025% 00897310 RETIN

More information

2014 Quantity Limits (QL) Criteria

2014 Quantity Limits (QL) Criteria 2014 Quantity Limits (QL) Criteria Certain drugs covered through your EmblemHealth Medicare HMO/PPO Medicare Plan are covered for only a limited quantity. We do this to ensure compliance with the US Food

More information

ATYPICAL ANTIPSYCHOTICS

ATYPICAL ANTIPSYCHOTICS Step Therapy CareOregon 2018 Last Updated: 07/27/2018 ATYPICAL ANTIPSYCHOTICS Fanapt Fanapt Titration Pack Paliperidone Er Vraylar The following criteria applies to members who newly start on the drug:

More information

Step Therapy Requirements

Step Therapy Requirements An Independent Licensee of the Blue Cross and Blue Shield Association Step Therapy Requirements Effective: 12/01/2017 Updated 11/2017 H0302_2_2014 CMS Accepted 05/05/2014 1 ABILIFY Abilify 10 mg tablet

More information

ARBS MEDICATION(S) SUBJECT TO STEP THERAPY DIOVAN HCT MG TAB, DIOVAN HCT MG TABLET

ARBS MEDICATION(S) SUBJECT TO STEP THERAPY DIOVAN HCT MG TAB, DIOVAN HCT MG TABLET ARBS DIOVAN HCT 160-12.5 MG TAB, DIOVAN HCT 80-12.5 MG TABLET 30-day trial of a Step 1 drug in the previous 120 days is required. Step 1 Drugs: Losartan, Losartan/HCTZ PAGE 1 LAST UPDATED 05/2016 BILE

More information

Fee-for-Service Pharmacy Provider Notice #216 ** March 2016 PDL Changes ** Existing Drug Classes

Fee-for-Service Pharmacy Provider Notice #216 ** March 2016 PDL Changes ** Existing Drug Classes Fee-for-Service Pharmacy Provider Notice #216 ** March 2016 PDL Changes ** December 19, 2016 Please be advised that the Department for Medicaid Services (DMS) is making changes to the Kentucky Medicaid

More information

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM Value Based Tier Drugs are selected for the management of Asthma, Diabetes, Hypertension and Hyperlipidemia. These drugs are covered at no charge or at a reduced cost share. Medications are under continual

More information

STEP THERAPY CRITERIA

STEP THERAPY CRITERIA STEP THERAPY This is a complete list of drugs that have written coverage determination policies. Drugs on this list do not indicate that this particular drug will be covered under your medical or prescription

More information

DIABETES (1 of 5) Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10. Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10 $0 $0 $0

DIABETES (1 of 5) Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10. Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10 $0 $0 $0 Metformin DIABETES (1 of 5) Glucophage Glucophage XR ER $7 (500mg) $7 (500mg) $5 $5 500mg, 750mg only 500mg, 750mg only Sulfonylurea/Combinations Amaryl Glucotrol glimepiride glipizide $5 $5 Glucotrol

More information

Step Therapy Criteria 2019

Step Therapy Criteria 2019 Step Therapy 2019 For information on obtaining an updated coverage determination or an exception to a coverage determination please call Freedom Health Member Services at 1-800-401-2740 or, for TTY/TDD

More information

2016 Step Therapy (ST) Criteria

2016 Step Therapy (ST) Criteria 2016 Step Therapy (ST) Some drugs require step therapy pre-approval. This means that your doctor must have you first try a different drug to treat your medical condition before we will cover a drug that

More information

Velphoro (sucroferric oxyhydroxide)

Velphoro (sucroferric oxyhydroxide) STRENGTH DOSAGE FORM ROUTE GPID 500mg chewable tablet oral 36003 MANUFACTURER Fresenius Medical Care North America INDICATION(S) For the control of serum phosphorus levels in patients with chronic kidney

More information

Inhaled Corticosteroids Drug Class Prior Authorization Protocol

Inhaled Corticosteroids Drug Class Prior Authorization Protocol Inhaled Corticosteroids Drug Class Prior Authorization Protocol Line of Business: Medi-Cal P&T Approval Date: February 21, 2018 Effective Date: April 1, 2018 This policy has been developed through review

More information

NOTIFICATION OF FORMULARY CHANGES

NOTIFICATION OF FORMULARY CHANGES NOTIFICATION OF CHANGES The following summary describes changes to the 2018 Presbyterian Senior Care (HMO)/(HMO-POS), Presbyterian MediCare PPO and formularies. The formulary may change at any time. You

More information